Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 28.97% is in line with its 5-year average of 31.24%, around the middle of its 5-year range (-9.23%–80.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 34.49% above its 12-month average of 21.54%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 28.97%.
RETURN ON EQUITY (ROE)
28.97%
RETURN ON EQUITY (ROE) AVG TTM
21.54%
RETURN ON EQUITY (ROE) AVG 3Y
18.13%
RETURN ON EQUITY (ROE) AVG 5Y
31.24%
RETURN ON EQUITY (ROE) AVG 10Y
34.52%
RETURN ON EQUITY (ROE) AVG 15Y
24.76%
RETURN ON EQUITY (ROE) AVG 20Y
21.69%
CURRENT VS TTM AVG
+34.49%
CURRENT VS 3Y AVG
+59.73%
CURRENT VS 5Y AVG
-7.29%
CURRENT VS 10Y AVG
-16.08%
CURRENT VS 15Y AVG
+17.00%
CURRENT VS 20Y AVG
+33.52%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+168.95%
vs the sector median at left
Innoviva, Inc.
Market Cap
$1.54B
Return on Equity (ROE)
28.97%
TTM Avg
21.54%
3Y Avg
18.13%
5Y Avg
31.24%
Market Cap
$1.54B
Return on Equity (ROE)
-1462.12%
TTM Avg
-276.13%
3Y Avg
-155.50%
5Y Avg
-107.48%
Market Cap
$1.50B
Return on Equity (ROE)
45.63%
TTM Avg
28.57%
3Y Avg
-115.12%
5Y Avg
-36.89%
Market Cap
$1.57B
Return on Equity (ROE)
-60.17%
TTM Avg
-20.40%
3Y Avg
-40.27%
5Y Avg
-36.46%
Market Cap
$1.50B
Return on Equity (ROE)
27.24%
TTM Avg
-16.62%
3Y Avg
-27.07%
5Y Avg
-49.65%
Market Cap
$1.49B
Return on Equity (ROE)
-32.43%
TTM Avg
-24.32%
3Y Avg
8.11%
5Y Avg
8.11%
Market Cap
$1.59B
Return on Equity (ROE)
-67.40%
TTM Avg
-53.05%
3Y Avg
2.62%
5Y Avg
2.10%
Market Cap
$1.48B
Return on Equity (ROE)
25.87%
TTM Avg
21.38%
3Y Avg
13.81%
5Y Avg
16.13%
Market Cap
$1.48B
Return on Equity (ROE)
-17.32%
TTM Avg
-19.51%
3Y Avg
-16.07%
5Y Avg
-12.58%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.54B | 28.97% | 21.54% | 18.13% | 31.24% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -1462.12% | -276.13% | -155.50% | -107.48% |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | 45.63% | 28.57% | -115.12% | -36.89% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -60.17% | -20.40% | -40.27% | -36.46% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 27.24% | -16.62% | -27.07% | -49.65% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | -32.43% | -24.32% | 8.11% | 8.11% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -67.40% | -53.05% | 2.62% | 2.10% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 25.87% | 21.38% | 13.81% | 16.13% |
| GH Research PLC (GHRS)vs › | $1.48B | -17.32% | -19.51% | -16.07% | -12.58% |
| uniQure N.V. (QURE)vs › | $1.60B | -77.83% | 1723.94% | 818.18% | 546.13% |
ROE
29.0%
ROA
21.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 28.97% |
| 2026-03-31 | 37.59% |
| 2025-12-31 | 23.12% |
| 2025-09-30 | 12.61% |
| 2025-06-30 | 5.41% |
| 2025-03-31 | -9.23% |
| 2024-12-31 | 3.38% |
| 2024-09-30 | 9.66% |
| 2024-06-30 | 21.85% |
| 2024-03-31 | 25.78% |
| 2023-12-31 | 26.63% |
| 2023-09-30 | 7.95% |
| 2023-06-30 | 42.04% |
| 2023-03-31 | 41.50% |
| 2022-12-31 | 37.81% |
| 2022-09-30 | 45.62% |
| 2022-06-30 | 25.62% |
| 2022-03-31 | 48.50% |
| 2021-12-31 | 64.10% |
| 2021-09-30 | 76.81% |
| 2021-06-30 | 80.41% |
| 2021-03-31 | 39.89% |
| 2020-12-31 | 41.56% |
| 2020-09-30 | 44.58% |
| 2020-06-30 | 49.91% |
| 2020-03-31 | 49.78% |
| 2019-12-31 | 50.17% |
| 2019-09-30 | 140.46% |
| 2019-06-30 | 168.68% |
| 2019-03-31 | 212.10% |
| 2018-12-31 | 257.23% |
| 2014-03-31 | -76.37% |
| 2013-12-31 | -57.07% |
| 2013-09-30 | -46.08% |
| 2013-06-30 | -163.23% |
| 2013-03-31 | -153.53% |
| 2012-12-31 | -11.96% |
| 2012-09-30 | -13.98% |
| 2012-06-30 | -10.65% |
| 2012-03-31 | -131.85% |
| 2007-03-31 | -818.63% |
| 2006-12-31 | -262.27% |
| 2006-09-30 | -181.23% |
| 2006-06-30 | -135.68% |
| 2006-03-31 | -102.00% |
| 2005-12-31 | -240.27% |
| 2005-09-30 | -132.54% |
| 2005-06-30 | -85.57% |
| 2005-03-31 | -70.40% |
